The Huntington's Scene In
New Zealand
Site Maintained by
Graham Taylor
|
Site Resources
available from the Homepage |
|
|
|
Articles taken from the March 2004
Huntington's News. The Quarterly Newsletter of the Huntington's Disease Associations of
New Zealand |
Simple
Sugar Curbs Huntington Disease, In Mice
By
Megan Rauscher
NEW
YORK (Reuters Health) - Huntington Disease is an inherited condition caused by a genetic
mutation that invariably leads to dementia and death, usually in adulthood. For people in
families with the disease, a genetic test can tell if they have inherited the mutation --
but many prefer not to be tested, because there is no cure.
Now comes
a ray of hope.
In mice
that develop a form of Huntington Disease, a non-toxic sugar compound called trehalose,
given by mouth, significantly extends life, according to Japanese researchers.
These
results "make trehalose promising as a therapeutic drug or lead compound" for
the treatment of Huntington Disease, Dr. Nobuyuki Nukina and colleagues from the RIKEN
Brain Science Institute in Saitama write in this week's online edition of Nature Medicine.
There is
considerable evidence that clumping in the brain of an abnormal, insoluble protein called
"huntingtin" causes Huntington Disease. Nukina's team found through lab
experiments that a number of sugars -- disaccharides -- inhibit this aggregation.
"Trehalose
has the strongest effect," he told Reuters Health.
Mice with
Huntington Disease given trehalose in drinking water had substantially fewer huntingtin
protein aggregates in the brain, less motor dysfunction, and lived significantly longer
than untreated animals.
However,
although trehalose appears to prevent the formation of new aggregates, it does not seem to
reverse existing formations.
"The
protection of aggregation formation is important to block the disease cascade,"
Nukina explained.
Trehalose,
which is turned into glucose in the body, did not alter blood levels of glucose in the
animals. This is notable, the researchers say, because people with Huntington Disease are
prone to develop diabetes.
"It
is necessary to evaluate the effectiveness, dose and safety of trehalose in human
trials," Nukina concluded.
The
researcher pointed out that trehalose may also have potential against other neurological
disorders caused by similar aggregation of proteins such as Alzheimer disease, Parkinson
disease, prion disease (such as the human version of mad cow disease), and Lou Gehrig
disease.